Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome.
Larouche
Jean-François
JF
Service d'Hématologie, Centre Hospitalier Lyon-Sud, 69310 Pierre-Bénite, France.
Berger
Françoise
F
Chassagne-Clément
Catherine
C
Ffrench
Martine
M
Callet-Bauchu
Evelyne
E
Sebban
Catherine
C
Ghesquières
Hervé
H
Broussais-Guillaumot
Florence
F
Salles
Gilles
G
Coiffier
Bertrand
B
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy; D018572:Disease-Free Survival; D005260:Female; D005602:France; D006801:Humans; D007150:Immunohistochemistry; D053208:Kaplan-Meier Estimate; D016403:Lymphoma, Large B-Cell, Diffuse / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010641:Phenotype; D018714:Radiotherapy, Adjuvant; D012008:Recurrence; D012189:Retrospective Studies; D016879:Salvage Therapy; D033581:Stem Cell Transplantation; D013997:Time Factors; D014182:Transplantation, Autologous; D016896:Treatment Outcome